STACEY CHUNG: Open Payments
NPI 1184385064 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 7 payments from 4 companies in 2025. Trend: 2023 $152 · 2024 $240 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $295 |
| Legend Biotech USA Inc. | 1 | $147 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: RYBREVANT, CARVYKTI, BREYANZI, TALVEY, BLENREP, TECVAYLI.
Industry payments across MA — which companies pay providers there.
